AIA
AZN icon

Aventus Investment Advisors’s AstraZeneca AZN Stock Holding History

Aventus Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.6K Hold
235
– – 0.03% 61
2026
Q1 		$46.3K Hold
235
– – 0.04% 58
2025
Q4 		$43.2K Hold
235
– – 0.04% 59
2025
Q3 		$36.1K Hold
235
– – 0.03% 64
2025
Q2 		$32.8K Buy
+235
New +$32.9K 0.03% 66

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Aventus Investment Advisors's AZN Position: Q2 2026 in Review

Aventus Investment Advisors held its AstraZeneca (AZN) position steady in Q2 2026 at 235 shares worth $44.6K. The position accounts for 0.03% of the portfolio, ranked #61.

Aventus Investment Advisors first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $46.3K in Q1 2026. 485 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Aventus Investment Advisors held 235 shares of AstraZeneca worth $44.6K as of Q2 2026.
  • Aventus Investment Advisors left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.03% of Aventus Investment Advisors's portfolio in Q2 2026, its #61 holding.
  • Aventus Investment Advisors first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • Aventus Investment Advisors's AstraZeneca position peaked at $46.3K in Q1 2026.
  • 485 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Aventus Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.